Novel |
ADH5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
|
- NADH
- Lauric acid
- 12-Hydroxydodecanoic Acid
- S-Hydroxymethyl Glutathione
|
|
Novel |
AK4 |
adenylate kinase 4 |
- Interconversion of nucleotide di- and triphosphates
|
|
|
Novel |
AMER1 |
APC membrane recruitment protein 1 |
- Degradation of beta-catenin by the destruction complex
- Beta-catenin phosphorylation cascade
- Disassembly of the destruction complex and recruitment of AXIN to the membrane
- Disassembly of the destruction complex and recruitment of AXIN to the membrane
- Signaling by GSK3beta mutants
- CTNNB1 S33 mutants aren't phosphorylated
- CTNNB1 S37 mutants aren't phosphorylated
- CTNNB1 S45 mutants aren't phosphorylated
- CTNNB1 T41 mutants aren't phosphorylated
- APC truncation mutants have impaired AXIN binding
- AXIN missense mutants destabilize the destruction complex
- Truncations of AMER1 destabilize the destruction complex
- Neddylation
- KEAP1-NFE2L2 pathway
|
|
- Osteopathia striata with cranial sclerosis
|
Novel |
ANKS1A |
ankyrin repeat and sterile alpha motif domain containing 1A |
|
|
|
Novel |
ARPC1B |
actin related protein 2/3 complex subunit 1B |
- Regulation of actin dynamics for phagocytic cup formation
- Regulation of actin dynamics for phagocytic cup formation
- EPHB-mediated forward signaling
- RHO GTPases Activate WASPs and WAVEs
- RHO GTPases Activate WASPs and WAVEs
- FCGR3A-mediated phagocytosis
- FCGR3A-mediated phagocytosis
|
- N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide
- (2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one
|
|
Novel |
ASTN1 |
astrotactin 1 |
|
|
|
Novel |
ATF5 |
activating transcription factor 5 |
- Response of EIF2AK1 (HRI) to heme deficiency
- Mitochondrial unfolded protein response (UPRmt)
- Mitochondrial unfolded protein response (UPRmt)
|
|
|
Novel |
ATG5 |
autophagy related 5 |
- Macroautophagy
- PINK1-PRKN Mediated Mitophagy
- Receptor Mediated Mitophagy
- Negative regulators of DDX58/IFIH1 signaling
|
|
|
Novel |
BAD |
BCL2 associated agonist of cell death |
- Activation of BAD and translocation to mitochondria
- Activation of BAD and translocation to mitochondria
- BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
- NRAGE signals death through JNK
- AKT phosphorylates targets in the cytosol
- Constitutive Signaling by AKT1 E17K in Cancer
|
|
|
Novel |
BNIP3L |
BCL2 interacting protein 3 like |
- TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
|
|
|
Novel |
BPTF |
bromodomain PHD finger transcription factor |
|
|
|
Novel |
BTRC |
beta-transducin repeat containing E3 ubiquitin protein ligase |
- Activation of NF-kappaB in B cells
- Prolactin receptor signaling
- SCF-beta-TrCP mediated degradation of Emi1
- Vpu mediated degradation of CD4
- Degradation of beta-catenin by the destruction complex
- Downstream TCR signaling
- Regulation of PLK1 Activity at G2/M Transition
- FCERI mediated NF-kB activation
- Deactivation of the beta-catenin transactivating complex
- Dectin-1 mediated noncanonical NF-kB signaling
- CLEC7A (Dectin-1) signaling
- Degradation of GLI1 by the proteasome
- Degradation of GLI2 by the proteasome
- GLI3 is processed to GLI3R by the proteasome
- NIK-->noncanonical NF-kB signaling
- MAP3K8 (TPL2)-dependent MAPK1/3 activation
- Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A
- Neddylation
- Interleukin-1 signaling
- GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2
- Antigen processing: Ubiquitination & Proteasome degradation
- GSK3B-mediated proteasomal degradation of PD-L1(CD274)
- Degradation of CRY and PER proteins
|
|
|
Novel |
C2orf68 |
chromosome 2 open reading frame 68 |
|
|
|
Novel |
C6orf132 |
chromosome 6 open reading frame 132 |
|
|
|
Novel |
CARD10 |
caspase recruitment domain family member 10 |
|
|
|
Novel |
CARM1 |
coactivator associated arginine methyltransferase 1 |
- BMAL1:CLOCK,NPAS2 activates circadian expression
- PPARA activates gene expression
- PPARA activates gene expression
- Transcriptional activation of mitochondrial biogenesis
- Activation of gene expression by SREBF (SREBP)
- RMTs methylate histone arginines
- Transcriptional regulation of white adipocyte differentiation
- Regulation of lipid metabolism by PPARalpha
- TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
- Estrogen-dependent gene expression
- Cytoprotection by HMOX1
- Heme signaling
- Expression of BMAL (ARNTL), CLOCK, and NPAS2
- RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression
|
|
|
Novel |
CAT |
catalase |
- Detoxification of Reactive Oxygen Species
- Neutrophil degranulation
- Peroxisomal protein import
- Peroxisomal protein import
- FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
- Mitochondrial unfolded protein response (UPRmt)
|
- Fomepizole
- Cannabidiol
- Benzoyl peroxide
- Medical Cannabis
- Nabiximols
|
- Acatalasia, including: Acatalasemia; Takahara's disease; Hypocatalasemia
|
Novel |
CCNB1IP1 |
cyclin B1 interacting protein 1 |
|
|
|
Novel |
CDH1 |
cadherin 1 |
- Degradation of the extracellular matrix
- Degradation of the extracellular matrix
- Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
- Integrin cell surface interactions
- Apoptotic cleavage of cell adhesion proteins
- Adherens junctions interactions
- RHO GTPases activate IQGAPs
- InlA-mediated entry of Listeria monocytogenes into host cells
- Regulation of CDH1 Function
- Regulation of CDH1 mRNA translation by microRNAs
- Degradation of CDH1
- Regulation of CDH1 posttranslational processing and trafficking to plasma membrane
- Formation of definitive endoderm
- Transcriptional and post-translational regulation of MITF-M expression and activity
- Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition
- Developmental Lineage of Mammary Gland Luminal Epithelial Cells
- Developmental Lineage of Mammary Gland Myoepithelial Cells
- Developmental Lineage of Mammary Stem Cells
|
|
- Penile cancer
- Breast cancer
- Gastric cancer
- Nasopharyngeal cancer
- Hepatocellular carcinoma
- Thyroid cancer
|
Novel |
CDK6 |
cyclin dependent kinase 6 |
- Oxidative Stress Induced Senescence
- Senescence-Associated Secretory Phenotype (SASP)
- Oncogene Induced Senescence
- Cyclin D associated events in G1
- Regulation of RUNX1 Expression and Activity
- Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6
- Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6
- Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)
- Drug-mediated inhibition of CDK4/CDK6 activity
|
- Alvocidib
- (2S)-2-({6-[(3-Amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methyl-1-butanol
- Fisetin
- Palbociclib
- Ribociclib
- Abemaciclib
- Trilaciclib
|
|